MarketPeel
Insider Trading Intelligence
Pricing
…
NK

Neil Kumar

BBIO
CHIEF EXECUTIVE OFFICER · BRIDGEBIO PHARMA, INC. · CIK 0001742485
FILING MIX · LIFETIME14%/86%
BUYS
51
SELLS
302
TOTAL VALUE
$168.68M
COMPANIES
3
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
593,631
AVG SELL PX
$37.26
TRADE KIND
SHOWING 353 / 353
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
180 backtested trades · 8 horizons · 317 pending
Forward-return performance of every backtestable P/S trade by Neil Kumar, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d180+30.00%+2.05%+0.76%+1.29%+0.81%3.05
14d180+34.44%+1.25%+0.19%+1.06%+1.50%1.48
30d180+39.44%+3.60%+1.20%+2.40%+0.35%2.79
60d180(11 pending)+38.46%+9.04%+2.94%+6.10%+4.75%4.04
90d180(19 pending)+46.58%+11.35%+4.05%+7.30%+2.13%3.90
180d180(57 pending)+22.76%+38.52%+11.22%+31.78%+20.64%8.13
1y180(104 pending)+3.95%+112.64%+30.66%+81.98%+71.33%11.41
2y180(126 pending)+77.78%-14.72%+50.59%-65.31%-107.58%-4.84
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
BBIO · 528,539 shares · as of Jun 5, 2026
01,424,6122,849,2244,273,8355,698,447202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 51 buys / 302 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
BBOT
BRIDGEBIO ONCOLOGY THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
31,675——31,675Jun 16, 2026Jun 18, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
8,437$67.88$572.7K4,322,862Jun 5, 2026Jun 8, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
8,437$67.88$572.7K520,102Jun 5, 2026Jun 8, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
4,416$68.96$304.5K515,686Jun 5, 2026Jun 8, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
7,147$67.20$480.3K528,539Jun 5, 2026Jun 8, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
4,415$68.96$304.5K4,318,447Jun 5, 2026Jun 8, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
7,148$67.20$480.3K4,331,299Jun 5, 2026Jun 8, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
2,200$65.72$144.6K4,356,247Jun 4, 2026Jun 8, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
2,200$65.72$144.6K553,486Jun 4, 2026Jun 8, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
450$68.27$30.7K4,338,447Jun 4, 2026Jun 8, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
450$68.27$30.7K535,686Jun 4, 2026Jun 8, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
15,921$67.74$1.08M536,136Jun 4, 2026Jun 8, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
1,429$66.72$95.3K4,354,818Jun 4, 2026Jun 8, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
1,429$66.72$95.3K552,057Jun 4, 2026Jun 8, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
15,921$67.74$1.08M4,338,897Jun 4, 2026Jun 8, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
800$70.92$56.7K243,327May 21, 2026May 26, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
6,725$68.30$459.3K260,449May 21, 2026May 26, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
2,256$67.57$152.4K267,174May 21, 2026May 26, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
5,072$69.22$351.1K255,377May 21, 2026May 26, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
11,250$70.48$792.9K244,127May 21, 2026May 26, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
Chief Executive Officer
33,544——267,995May 16, 2026May 19, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
Chief Executive Officer
33,544——100,632May 16, 2026May 19, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
Chief Executive Officer
19,599——137,195May 16, 2026May 19, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
Chief Executive Officer
6,519——97,794May 16, 2026May 19, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
Chief Executive Officer
6,519——305,666May 16, 2026May 19, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
Chief Executive Officer
19,599——287,594May 16, 2026May 19, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
Chief Executive Officer
36,236$66.13$2.40M269,430May 16, 2026May 19, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
Chief Executive Officer
11,553——127,092May 16, 2026May 19, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
Chief Executive Officer
11,553——299,147May 16, 2026May 19, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
13,974$66.65$931.4K4,364,473May 8, 2026May 11, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
13,973$66.65$931.3K561,713May 8, 2026May 11, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
950$68.35$64.9K4,358,447May 8, 2026May 11, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
950$68.35$64.9K555,686May 8, 2026May 11, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
5,077$67.35$341.9K556,636May 8, 2026May 11, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
5,076$67.35$341.8K4,359,397May 8, 2026May 11, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
11,217$67.50$757.1K584,469May 7, 2026May 11, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
11,217$67.49$757.1K4,387,230May 7, 2026May 11, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
450$69.09$31.1K575,686May 7, 2026May 11, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
449$69.09$31.0K4,378,447May 7, 2026May 11, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
8,334$68.38$569.9K4,378,896May 7, 2026May 11, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
8,333$68.38$569.8K576,136May 7, 2026May 11, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
20,000$74.60$1.49M4,398,447Apr 10, 2026Apr 13, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
20,000$74.60$1.49M595,686Apr 10, 2026Apr 13, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
5,128$74.57$382.4K4,426,247Apr 9, 2026Apr 13, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
7,072$73.64$520.8K4,431,375Apr 9, 2026Apr 13, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
5,300$74.60$395.4K623,186Apr 9, 2026Apr 13, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
7,500$75.55$566.7K615,686Apr 9, 2026Apr 13, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
7,800$75.53$589.1K4,418,447Apr 9, 2026Apr 13, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
7,200$73.64$530.2K628,486Apr 9, 2026Apr 13, 2026 ↗View →
MAZE
MAZE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
33,417——33,417Mar 27, 2026Mar 31, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASEGRANT
Stock grant
104,313——104,313Mar 17, 2026Mar 19, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASEGRANT
Stock grant
40,570——40,570Mar 17, 2026Mar 19, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
9,759$69.23$675.6K4,438,447Mar 13, 2026Mar 16, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
10,310$69.20$713.4K635,686Mar 13, 2026Mar 16, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
10,241$68.39$700.3K4,448,206Mar 13, 2026Mar 16, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
9,690$68.36$662.4K645,996Mar 13, 2026Mar 16, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
5,363$69.32$371.8K655,986Mar 12, 2026Mar 16, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
300$70.15$21.0K4,458,447Mar 12, 2026Mar 16, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
13,885$68.47$950.7K4,464,562Mar 12, 2026Mar 16, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
14,337$68.48$981.8K661,349Mar 12, 2026Mar 16, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
300$70.15$21.0K655,686Mar 12, 2026Mar 16, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
5,815$69.29$402.9K4,458,747Mar 12, 2026Mar 16, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
18,923$71.03$1.34M243,581Feb 19, 2026Feb 23, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
8,528$72.08$614.7K235,053Feb 19, 2026Feb 23, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
602$72.80$43.8K234,451Feb 19, 2026Feb 23, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
Chief Executive Officer
33,544——134,176Feb 16, 2026Feb 18, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
Chief Executive Officer
19,600——156,794Feb 16, 2026Feb 18, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
Chief Executive Officer
11,554——293,474Feb 16, 2026Feb 18, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
Chief Executive Officer
11,554——138,645Feb 16, 2026Feb 18, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
Chief Executive Officer
33,544——262,320Feb 16, 2026Feb 18, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
Chief Executive Officer
30,970$75.25$2.33M262,504Feb 16, 2026Feb 18, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
Chief Executive Officer
19,600——281,920Feb 16, 2026Feb 18, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
7,806$70.69$551.8K687,880Feb 11, 2026Feb 12, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
4,404$72.65$319.9K4,482,408Feb 11, 2026Feb 12, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
4,484$72.64$325.7K679,680Feb 11, 2026Feb 12, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
3,775$71.46$269.8K4,486,812Feb 11, 2026Feb 12, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
3,716$71.44$265.5K684,164Feb 11, 2026Feb 12, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
3,994$73.25$292.6K675,686Feb 11, 2026Feb 12, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
7,860$70.70$555.7K4,490,587Feb 11, 2026Feb 12, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
3,961$73.25$290.1K4,478,447Feb 11, 2026Feb 12, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
14,201$71.80$1.02M701,485Feb 10, 2026Feb 12, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
5,799$72.28$419.2K695,686Feb 10, 2026Feb 12, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
5,960$72.27$430.8K4,498,447Feb 10, 2026Feb 12, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
14,040$71.80$1.01M4,504,407Feb 10, 2026Feb 12, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
1,855$78.10$144.9K4,518,447Jan 9, 2026Jan 12, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
10,519$77.61$816.4K716,061Jan 9, 2026Jan 12, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
2,151$75.75$162.9K733,535Jan 9, 2026Jan 12, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
1,401$75.61$105.9K4,537,046Jan 9, 2026Jan 12, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
6,955$76.72$533.6K726,580Jan 9, 2026Jan 12, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
375$78.19$29.3K715,686Jan 9, 2026Jan 12, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
6,067$76.53$464.3K4,530,979Jan 9, 2026Jan 12, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
10,677$77.46$827.0K4,520,302Jan 9, 2026Jan 12, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
400$75.16$30.1K735,686Jan 8, 2026Jan 12, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
300$75.20$22.6K4,538,447Jan 8, 2026Jan 12, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
8,085$74.38$601.3K736,086Jan 8, 2026Jan 12, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
8,135$74.38$605.1K4,538,747Jan 8, 2026Jan 12, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
11,565$73.65$851.8K4,546,882Jan 8, 2026Jan 12, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
11,515$73.64$848.0K744,171Jan 8, 2026Jan 12, 2026 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
1,700$75.24$127.9K228,776Dec 15, 2025Dec 16, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
28,311$74.60$2.11M230,476Dec 15, 2025Dec 16, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
Chief Executive Officer
30,964$75.15$2.33M258,787Dec 12, 2025Dec 16, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
Chief Executive Officer
60,975——60,976Dec 12, 2025Dec 16, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
Chief Executive Officer
60,975——289,751Dec 12, 2025Dec 16, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
7,712$73.75$568.8K4,558,447Dec 5, 2025Dec 8, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
7,483$73.76$552.0K755,686Dec 5, 2025Dec 8, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
12,517$73.05$914.3K763,169Dec 5, 2025Dec 8, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
12,288$73.04$897.5K4,566,159Dec 5, 2025Dec 8, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
5,700$74.80$426.4K4,578,447Dec 4, 2025Dec 8, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
12,192$74.42$907.4K781,394Dec 4, 2025Dec 8, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
2,100$73.16$153.6K4,596,347Dec 4, 2025Dec 8, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
5,708$74.80$426.9K775,686Dec 4, 2025Dec 8, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
2,100$73.16$153.6K793,586Dec 4, 2025Dec 8, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
12,200$74.42$908.0K4,584,147Dec 4, 2025Dec 8, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
14,299$65.90$942.4K234,232Nov 20, 2025Nov 24, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
6,401$64.97$415.9K248,531Nov 20, 2025Nov 24, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
5,456$66.71$364.0K228,776Nov 20, 2025Nov 24, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
Chief Executive Officer
19,599——176,394Nov 16, 2025Nov 18, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
Chief Executive Officer
19,599——276,233Nov 16, 2025Nov 18, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
Chief Executive Officer
33,544——256,634Nov 16, 2025Nov 18, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
Chief Executive Officer
11,554——287,787Nov 16, 2025Nov 18, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
Chief Executive Officer
33,544——167,720Nov 16, 2025Nov 18, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
Chief Executive Officer
11,554——150,199Nov 16, 2025Nov 18, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
Chief Executive Officer
32,855$66.39$2.18M254,932Nov 16, 2025Nov 18, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
12,492$61.14$763.8K4,605,955Nov 7, 2025Nov 10, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
200$62.81$12.6K4,598,447Nov 7, 2025Nov 10, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
7,546$61.87$466.8K795,906Nov 7, 2025Nov 10, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
7,308$61.87$452.2K4,598,647Nov 7, 2025Nov 10, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
12,234$61.13$747.9K803,452Nov 7, 2025Nov 10, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
220$62.79$13.8K795,686Nov 7, 2025Nov 10, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
7,371$63.56$468.5K815,786Nov 6, 2025Nov 10, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
12,529$62.91$788.2K823,157Nov 6, 2025Nov 10, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
100$64.39$6.4K815,686Nov 6, 2025Nov 10, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
100$64.39$6.4K4,618,447Nov 6, 2025Nov 10, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
12,576$62.91$791.2K4,625,871Nov 6, 2025Nov 10, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
7,324$63.55$465.4K4,618,547Nov 6, 2025Nov 10, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
20,000$54.80$1.10M835,686Oct 9, 2025Oct 10, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
20,000$54.80$1.10M4,638,447Oct 9, 2025Oct 10, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
11,295$55.09$622.2K855,686Oct 8, 2025Oct 10, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
8,706$54.39$473.5K4,669,741Oct 8, 2025Oct 10, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
8,705$54.39$473.5K866,981Oct 8, 2025Oct 10, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
11,294$55.09$622.2K4,658,447Oct 8, 2025Oct 10, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
2,300$51.95$119.5K4,696,147Sep 5, 2025Sep 8, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
16,900$53.16$898.4K876,486Sep 5, 2025Sep 8, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
2,300$51.96$119.5K893,386Sep 5, 2025Sep 8, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
900$53.80$48.4K4,678,447Sep 5, 2025Sep 8, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
16,800$53.16$893.1K4,679,347Sep 5, 2025Sep 8, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
800$53.80$43.0K875,686Sep 5, 2025Sep 8, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
14,558$51.16$744.7K901,128Sep 4, 2025Sep 8, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
5,442$51.85$282.2K895,686Sep 4, 2025Sep 8, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
5,475$51.85$283.9K4,698,447Sep 4, 2025Sep 8, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
14,525$51.15$743.0K4,703,922Sep 4, 2025Sep 8, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
25,728$48.81$1.26M223,518Aug 20, 2025Aug 22, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
428$49.25$21.1K223,090Aug 20, 2025Aug 22, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
Chief Executive Officer
33,544——201,264Aug 16, 2025Aug 19, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
Chief Executive Officer
11,554——161,753Aug 16, 2025Aug 19, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
Chief Executive Officer
19,599——195,993Aug 16, 2025Aug 19, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
Chief Executive Officer
64,697——282,101Aug 16, 2025Aug 19, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
Chief Executive Officer
32,855$51.32$1.69M249,246Aug 16, 2025Aug 19, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
8,205$46.71$383.3K915,686Aug 8, 2025Aug 11, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
11,795$45.88$541.2K923,891Aug 8, 2025Aug 11, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
11,795$45.88$541.2K4,726,652Aug 8, 2025Aug 11, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
8,205$46.71$383.3K4,718,447Aug 8, 2025Aug 11, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
13,216$45.64$603.2K4,738,447Aug 7, 2025Aug 11, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
13,216$45.64$603.2K935,686Aug 7, 2025Aug 11, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
6,784$45.09$305.9K4,751,663Aug 7, 2025Aug 11, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
6,784$45.09$305.9K948,902Aug 7, 2025Aug 11, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
20,000$42.73$854.5K955,686Jul 2, 2025Jul 2, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
20,000$42.73$854.5K4,758,447Jul 2, 2025Jul 2, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
18,300$42.50$777.8K4,780,147Jul 1, 2025Jul 2, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
1,700$42.88$72.9K4,778,447Jul 1, 2025Jul 2, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
1,600$42.89$68.6K975,686Jul 1, 2025Jul 2, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
18,400$42.51$782.1K977,286Jul 1, 2025Jul 2, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
75,000$33.40$2.50M4,798,447May 20, 2025May 20, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
25,756$33.32$858.3K217,804May 19, 2025May 20, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
400$33.75$13.5K217,404May 19, 2025May 20, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
Chief Executive Officer
32,854$33.84$1.11M243,560May 16, 2025May 20, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
Chief Executive Officer
19,599——215,592May 16, 2025May 20, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
Chief Executive Officer
33,544——234,808May 16, 2025May 20, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
Chief Executive Officer
11,553——173,307May 16, 2025May 20, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
Chief Executive Officer
64,696——276,414May 16, 2025May 20, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
75,000$34.11$2.56M4,873,447Apr 22, 2025Apr 24, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
75,000$36.87$2.76M4,948,447Mar 25, 2025Mar 27, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASEGRANT
Stock grant
184,860——184,860Mar 19, 2025Mar 21, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASEGRANT
Stock grant
71,208——71,208Mar 19, 2025Mar 21, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
37,899$33.36$1.26M5,060,548Feb 25, 2025Feb 27, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
37,101$33.79$1.25M5,023,447Feb 25, 2025Feb 27, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
76$36.56$2.8K211,718Feb 19, 2025Feb 19, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
31,467$36.14$1.14M211,794Feb 19, 2025Feb 19, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
Chief Executive Officer
23,996$34.90$837.5K243,261Feb 16, 2025Feb 19, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
Chief Executive Officer
19,600——235,191Feb 16, 2025Feb 19, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
Chief Executive Officer
55,539——267,257Feb 16, 2025Feb 19, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
Chief Executive Officer
2,395——0Feb 16, 2025Feb 19, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
Chief Executive Officer
33,544——268,352Feb 16, 2025Feb 19, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
4,000$36.82$147.3K5,098,447Jan 29, 2025Jan 30, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
269,068$36.34$9.78M5,102,447Jan 29, 2025Jan 30, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
326,932$36.29$11.86M5,371,515Jan 28, 2025Jan 30, 2025 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASEGRANT
Gift
4,685,725——5,698,447Dec 24, 2024Dec 27, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALEGRANT
Gift
4,685,725——211,718Dec 24, 2024Dec 27, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASEGRANT
Stock grant
121,951——121,951Dec 10, 2024Dec 12, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
25,514$22.39$571.1K4,899,318Nov 19, 2024Nov 20, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
1,875$22.76$42.7K4,897,443Nov 19, 2024Nov 20, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
Chief Executive Officer
28,148$23.72$667.7K4,924,832Nov 16, 2024Nov 19, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
Chief Executive Officer
33,544——301,896Nov 16, 2024Nov 19, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
Chief Executive Officer
2,394——2,395Nov 16, 2024Nov 19, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
Chief Executive Officer
19,599——254,791Nov 16, 2024Nov 19, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
Chief Executive Officer
55,537——4,952,980Nov 16, 2024Nov 19, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
16,192$24.39$394.9K4,897,443Aug 19, 2024Aug 20, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
11,197$25.13$281.4K4,897,443Aug 19, 2024Aug 20, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
Chief Executive Officer
28,148$24.40$686.8K4,924,832Aug 16, 2024Aug 20, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
Chief Executive Officer
19,599——274,390Aug 16, 2024Aug 20, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
Chief Executive Officer
33,544——335,440Aug 16, 2024Aug 20, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
Chief Executive Officer
2,394——4,789Aug 16, 2024Aug 20, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
Chief Executive Officer
55,537——4,952,980Aug 16, 2024Aug 20, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
30,748$31.04$954.4K4,897,443May 16, 2024May 17, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
19,599——293,989May 16, 2024May 17, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
33,544——368,984May 16, 2024May 17, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
CEO and President
60,667——4,928,191May 16, 2024May 17, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
5,130——0May 16, 2024May 17, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
2,394——7,183May 16, 2024May 17, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASEGRANT
Stock grant
45,140——45,140Mar 12, 2024Mar 14, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASEGRANT
Stock grant
313,588——313,588Mar 12, 2024Mar 14, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
CEO and President
102,249——4,915,446Feb 16, 2024Feb 21, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
5,129——5,130Feb 16, 2024Feb 21, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
61,182——0Feb 16, 2024Feb 21, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
2,394——9,577Feb 16, 2024Feb 21, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
47,922$37.21$1.78M4,867,524Feb 16, 2024Feb 21, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
33,544——402,528Feb 16, 2024Feb 21, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
51,352$29.10$1.49M4,813,397Nov 17, 2023Nov 20, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
200$29.55$5.9K4,813,197Nov 17, 2023Nov 20, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
33,544——436,072Nov 16, 2023Nov 20, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
2,394——11,971Nov 16, 2023Nov 20, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
5,129——10,259Nov 16, 2023Nov 20, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
50,697$28.86$1.46M4,864,749Nov 16, 2023Nov 20, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
CEO and President
102,249——4,915,446Nov 16, 2023Nov 20, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
61,182——61,182Nov 16, 2023Nov 20, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
51,552$28.59$1.47M4,813,197Aug 17, 2023Aug 18, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
61,182——122,364Aug 16, 2023Aug 18, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
2,394——14,365Aug 16, 2023Aug 18, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
5,130——15,388Aug 16, 2023Aug 18, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
50,698$29.80$1.51M4,864,749Aug 16, 2023Aug 18, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
CEO and President
102,250——4,915,447Aug 16, 2023Aug 18, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
33,544——469,616Aug 16, 2023Aug 18, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
51,552$14.01$722.2K4,813,197May 17, 2023May 18, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
CEO and President
102,249——4,915,446May 16, 2023May 18, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
5,129——20,518May 16, 2023May 18, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
50,697$14.09$714.3K4,864,749May 16, 2023May 18, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
2,394——16,759May 16, 2023May 18, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
61,182——183,546May 16, 2023May 18, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
33,544——503,160May 16, 2023May 18, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
120,000$14.18$1.70M1,012,722May 3, 2023May 5, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE10b5-1
10b5-1 plan
120,000$15.46$1.86M1,132,722Apr 5, 2023Apr 7, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
120,000$10.96$1.32M1,252,722Mar 3, 2023Mar 3, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
44,798$12.70$569.1K4,813,197Feb 17, 2023Feb 21, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
2,395——19,153Feb 16, 2023Feb 21, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
61,182——244,728Feb 16, 2023Feb 21, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
23,908$12.64$302.2K4,857,995Feb 16, 2023Feb 21, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
5,129——25,647Feb 16, 2023Feb 21, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
CEO and President
68,706——4,881,903Feb 16, 2023Feb 21, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASEGRANT
Stock grant
536,704——536,704Feb 10, 2023Feb 14, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASEGRANT
Stock grant
624,652——624,652Feb 10, 2023Feb 14, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
120,000$11.01$1.32M1,372,722Feb 3, 2023Feb 6, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
120,000$7.67$920.9K1,492,722Jan 5, 2023Jan 6, 2023 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
200,000——995,686Dec 21, 2022Dec 21, 2022 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
34,640$9.40$325.6K4,813,197Nov 17, 2022Nov 18, 2022 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
34,066$9.64$328.4K4,847,837Nov 16, 2022Nov 18, 2022 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
61,182——305,910Nov 16, 2022Nov 18, 2022 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
2,394——21,548Nov 16, 2022Nov 18, 2022 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
CEO and President
68,706——4,881,903Nov 16, 2022Nov 18, 2022 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
5,130——30,776Nov 16, 2022Nov 18, 2022 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
27,697$11.08$306.9K4,813,197Aug 16, 2022Aug 18, 2022 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
CEO and President
68,705——4,840,894Aug 16, 2022Aug 18, 2022 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
2,394——23,942Aug 16, 2022Aug 18, 2022 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
61,182——367,092Aug 16, 2022Aug 18, 2022 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
5,129——35,906Aug 16, 2022Aug 18, 2022 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
61,182——428,274May 16, 2022May 18, 2022 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
CEO and President
68,705——4,795,948May 16, 2022May 18, 2022 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
5,129——41,035May 16, 2022May 18, 2022 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
2,394——26,336May 16, 2022May 18, 2022 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
23,759$6.74$160.1K4,772,189May 16, 2022May 18, 2022 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASEGRANT
Stock grant
489,456——489,456Mar 16, 2022Mar 18, 2022 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
5,130——46,164Feb 16, 2022Feb 18, 2022 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
3,085$8.84$27.3K4,727,243Feb 16, 2022Feb 18, 2022 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
CEO and President
7,524——4,730,328Feb 16, 2022Feb 18, 2022 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
2,394——28,730Feb 16, 2022Feb 18, 2022 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASEGRANT
Stock grant
786,072——786,072Dec 3, 2021Dec 7, 2021 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
CEO and President
7,523——4,726,534Nov 16, 2021Nov 17, 2021 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
3,730$47.25$176.2K4,722,804Nov 16, 2021Nov 17, 2021 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
2,394——31,124Nov 16, 2021Nov 17, 2021 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
5,129——51,294Nov 16, 2021Nov 17, 2021 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
CEO and President
7,523——4,722,741Aug 16, 2021Aug 18, 2021 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
2,394——33,518Aug 16, 2021Aug 18, 2021 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
5,129——56,423Aug 16, 2021Aug 18, 2021 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
3,730$49.48$184.6K4,719,011Aug 16, 2021Aug 18, 2021 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
3,731$53.66$200.2K4,715,218May 16, 2021May 18, 2021 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
5,130——61,552May 16, 2021May 18, 2021 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
CEO and President
7,524——4,718,949May 16, 2021May 18, 2021 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
2,394——35,912May 16, 2021May 18, 2021 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
CEO and President
16,000$62.50$1.00M4,711,425Feb 17, 2021Feb 18, 2021 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
2,139$64.98$139.0K4,695,425Feb 16, 2021Feb 18, 2021 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
5,129——66,682Feb 16, 2021Feb 18, 2021 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
CEO and President
5,129——4,697,564Feb 16, 2021Feb 18, 2021 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASEGRANT
Stock grant
225,971——225,971Feb 10, 2021Feb 12, 2021 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASEGRANT
Stock grant
38,306——38,306Feb 10, 2021Feb 12, 2021 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
1,774$44.33$78.6K4,692,435Nov 16, 2020Nov 18, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
5,129——71,811Nov 16, 2020Nov 18, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
CEO and President
5,129——4,694,209Nov 16, 2020Nov 18, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
CEO and President
5,129——4,690,854Aug 16, 2020Aug 18, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
1,774$28.53$50.6K4,689,080Aug 16, 2020Aug 18, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
5,129——76,940Aug 16, 2020Aug 18, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
6,759$27.36$184.9K2,085,372Aug 4, 2020Aug 4, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
7,184$26.70$191.8K2,092,131Aug 4, 2020Aug 4, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
63,017$27.23$1.72M2,102,355Aug 3, 2020Aug 4, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
3,040$28.12$85.5K2,099,315Aug 3, 2020Aug 4, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
56,445$30.22$1.71M2,165,372Jul 2, 2020Jul 6, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
50,625$30.63$1.55M2,258,217Jul 1, 2020Jul 6, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
33,700$31.67$1.07M2,224,517Jul 1, 2020Jul 6, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
2,700$32.42$87.5K2,221,817Jul 1, 2020Jul 6, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
10,600$30.01$318.1K2,308,842Jun 8, 2020Jun 10, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASEGRANT
Stock grant
590,551——590,551Jun 3, 2020Jun 5, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
5,930$30.05$178.2K2,319,442Jun 3, 2020Jun 5, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASEGRANT
Stock grant
82,069——82,069Jun 3, 2020Jun 5, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
71,291$29.13$2.08M2,334,081Jun 1, 2020Jun 2, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
8,709$29.71$258.7K2,325,372Jun 1, 2020Jun 2, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
44,766$30.86$1.38M2,440,206May 5, 2020May 5, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
34,834$31.23$1.09M2,405,372May 5, 2020May 5, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
5,706$29.13$166.2K2,518,946May 4, 2020May 5, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
33,974$29.77$1.01M2,484,972May 4, 2020May 5, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
4,098$29.78$122.1K2,524,652May 1, 2020May 5, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
36,622$29.06$1.06M2,528,750May 1, 2020May 5, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
1,805$25.48$46.0K2,565,372Apr 7, 2020Apr 8, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
200$25.09$5.0K2,567,277Apr 3, 2020Apr 3, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
100$25.10$2.5K2,567,177Apr 3, 2020Apr 3, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
15,778$25.04$395.1K2,567,477Apr 2, 2020Apr 3, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
1,382$28.20$39.0K2,583,255Apr 1, 2020Apr 3, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
12,976$27.45$356.3K2,584,637Apr 1, 2020Apr 3, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
20,040$26.38$528.6K2,597,613Apr 1, 2020Apr 3, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
27,719$25.52$707.5K2,617,653Apr 1, 2020Apr 3, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
201$33.22$6.7K2,645,372Mar 3, 2020Mar 4, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
7,756$31.76$246.4K2,657,663Mar 3, 2020Mar 4, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
12,090$32.60$394.1K2,645,573Mar 3, 2020Mar 4, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
995$33.33$33.2K2,665,419Mar 2, 2020Mar 4, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
59,305$32.53$1.93M2,666,414Mar 2, 2020Mar 4, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
39,653$31.88$1.26M2,725,719Mar 2, 2020Mar 4, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
CEO and President
30,893$34.87$1.08M2,765,372Feb 5, 2020Feb 7, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
See Remarks
54,951$34.55$1.90M2,796,265Feb 4, 2020Feb 5, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
See Remarks
32,056$34.92$1.12M2,853,316Feb 3, 2020Feb 5, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
See Remarks
2,100$35.20$73.9K2,851,216Feb 3, 2020Feb 5, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
See Remarks
77,271$32.14$2.48M2,892,040Jan 3, 2020Jan 6, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
See Remarks
6,668$32.88$219.2K2,885,372Jan 3, 2020Jan 6, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
See Remarks
5,077$34.19$173.6K2,969,411Jan 2, 2020Jan 6, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
See Remarks
19,793$33.41$661.3K2,974,488Jan 2, 2020Jan 6, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
See Remarks
11,091$32.55$361.0K2,994,281Jan 2, 2020Jan 6, 2020 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
SALE
See Remarks
100$35.17$3.5K2,969,311Jan 2, 2020Jan 6, 2020 ↗View →
Other insiders · BBIO
Loading peer insiders…
About this filer
CIK 0001742485
ROLE
Chief Executive Officer
PRIMARY
BBIO
COMPANIES
3
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001742485DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback